| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1080/0167482X.2017.1286643 |
| P698 | PubMed publication ID | 28635528 |
| P50 | author | Lyn S Chitty | Q56526261 |
| P2093 | author name string | Celine Lewis | |
| Blanche Griffin | |||
| Samantha Edwards | |||
| P2860 | cites work | Prenatal-screening companies expand scope of DNA tests | Q56601191 |
| Non-invasive prenatal testing for Down's syndrome: pregnant women's views and likely uptake | Q56773442 | ||
| Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals | Q56780865 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Noninvasive prenatal testing for aneuploidy–ready for prime time? | Q57839590 | ||
| Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘False positive’ due to confined placental mosaicism | Q58028950 | ||
| Update on Procedure-Related Risks for Prenatal Diagnosis Techniques | Q22241937 | ||
| ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities | Q22242787 | ||
| DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| Noninvasive prenatal testing goes global | Q33957923 | ||
| Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing | Q33990071 | ||
| Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study | Q34132783 | ||
| Demographic and experiential correlates of public attitudes towards cell-free fetal DNA screening | Q34315923 | ||
| What women want: lead considerations for current and future applications of noninvasive prenatal testing in prenatal care | Q34330946 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing | Q34433169 | ||
| Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes | Q34452242 | ||
| Pregnancy: Prepare for unexpected prenatal test results | Q34479149 | ||
| Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies | Q34484712 | ||
| Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening | Q34508235 | ||
| Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing | Q35032051 | ||
| Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong | Q35060714 | ||
| Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age. | Q35447245 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake | Q35577099 | ||
| NIPT and Informed Consent: an Assessment of Patient Understanding of a Negative NIPT Result | Q35977714 | ||
| Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study | Q35979539 | ||
| Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. | Q36311237 | ||
| Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. | Q36354562 | ||
| Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities | Q36473401 | ||
| Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy | Q36902702 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis | Q37059519 | ||
| Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units | Q37067727 | ||
| Non-invasive fetal sex determination: impact on clinical practice | Q37075333 | ||
| Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing | Q37279297 | ||
| Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice? | Q37333449 | ||
| Global perspectives on clinical adoption of NIPT | Q37342219 | ||
| Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals | Q37351480 | ||
| Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age | Q37809306 | ||
| Screening for fetal aneuploidies at 11 to 13 weeks | Q37826399 | ||
| Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks | Q37826400 | ||
| Women's uptake of non-invasive DNA testing following a high-risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review | Q38284800 | ||
| Overview of the impact of noninvasive prenatal testing on diagnostic procedures | Q38418823 | ||
| Non-invasive prenatal testing for aneuploidy: a systematic review of Internet advertising to potential users by commercial companies and private health providers | Q38565317 | ||
| Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues | Q38577156 | ||
| Stakeholder attitudes and needs regarding cell-free fetal DNA testing | Q38729501 | ||
| For your interest? The ethical acceptability of using non-invasive prenatal testing to test 'purely for information'. | Q39072593 | ||
| NIPT: current utilization and implications for the future of prenatal genetic counseling. | Q39213958 | ||
| 'Hope for safe prenatal gene tests'. A content analysis of how the UK press media are reporting advances in non-invasive prenatal testing | Q40223085 | ||
| The multi-dimensional measure of informed choice: a validation study | Q40634859 | ||
| Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing | Q41060187 | ||
| Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology | Q41609597 | ||
| Public viewpoints on new non-invasive prenatal genetic tests | Q43465721 | ||
| Genetic counselors' experience with cell-free fetal DNA testing as a prenatal screening option for aneuploidy | Q43570601 | ||
| Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. | Q43981389 | ||
| Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience | Q44297084 | ||
| Non-invasive prenatal determination of fetal sex: translating research into clinical practice | Q44982893 | ||
| Uptake of noninvasive prenatal testing at a large academic referral center | Q44999703 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| A disability critique of the new prenatal test for Down syndrome | Q47797652 | ||
| Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. | Q50955444 | ||
| Non-invasive prenatal testing: ethics and policy considerations. | Q51074981 | ||
| Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake. | Q51461502 | ||
| Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. | Q51767524 | ||
| Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. | Q51836356 | ||
| Practical and ethical considerations of noninvasive prenatal diagnosis. | Q51933954 | ||
| Moral status of the fetus: fetal rights or maternal autonomy? | Q53399582 | ||
| P921 | main subject | medical ethics | Q237151 |
| research ethics | Q1132684 | ||
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2017-02-09 | |
| P1433 | published in | Journal of Psychosomatic Obstetrics & Gynecology | Q6295821 |
| P1476 | title | Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy |
| Q89635382 | Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec |
| Q91578289 | The Psychological Well-being of Pregnant Women Undergoing Prenatal Testing and Screening: A Narrative Literature Review |
| Q52319943 | Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions. |
Search more.